Application Sponsors
ANDA 211199 | ALKEM LABS LTD | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
None (Tentative Approval) | 003 |
None (Tentative Approval) | 004 |
Application Products
001 | TABLET;ORAL | 200MG | 0 | ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE |
002 | TABLET;ORAL | 400MG | 0 | ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE |
003 | TABLET;ORAL | 600MG | 0 | ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE |
004 | TABLET;ORAL | 800MG | 0 | ESLICARBAZEPINE ACETATE | ESLICARBAZEPINE ACETATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2019-01-28 | STANDARD |
Submissions Property Types
CDER Filings
ALKEM LABS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 211199
[companyName] => ALKEM LABS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"ESLICARBAZEPINE ACETATE","activeIngredients":"ESLICARBAZEPINE ACETATE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"ESLICARBAZEPINE ACETATE","activeIngredients":"ESLICARBAZEPINE ACETATE","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"ESLICARBAZEPINE ACETATE","activeIngredients":"ESLICARBAZEPINE ACETATE","strength":"600MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"ESLICARBAZEPINE ACETATE","activeIngredients":"ESLICARBAZEPINE ACETATE","strength":"800MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"01\/28\/2019","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-01-28
)
)